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Abstract 
The effects of variable calcium content on daily 
and fasting urinary calcium and other lithogenic solutes 
excretion, on the bone turnover index (fasting hydroxy-
proline urinary excretion) and on the calciotropic hor-
mones were studied in 312 stone former patients with an 
outpatient protocol and 15 stone former patients in an 
inpatient study. Furthermore in 60 of these patients, 30 
while on a low calcium diet (LCD) and 30 on a free cal-
cium home diet (FCD), the effects of an oral calcium 
load (OCL) on bone turnover index, calciotropic hor-
mones and calcium excretion were evaluated. The re-
sults demonstrate that an LCD is effective in reducing 
daily calcium excretion. Fasting calcium excretion is 
apparently not affected by changes in dietary calcium 
content. On the other hand, LCD induces a marked in-
crease in bone resorption, without apparent signs of in-
creased parathyroid activity. This may explain the 
failure to reduce fasting urinary calcium excretion by the 
LCD. The OCL greatly reduced bone resorption rate, 
without any change in calciotropic hormones, especially 
in patients on LCD. In conclusion, the LCD induces a 
reduction in the lithogenic factors in the urine of stone 
formers, but induces a marked increase in bone resorp-
tion. The lack of any change in fasting urinary calcium 
excretion in conditions of different dietary calcium in-
take may be due to an opposite change in the intestinal 
and osseous components that affect this parameter, and 
is therefore of little value. 
Key Words: Hypercalciuria, hydroxyproline, bone 
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Hypercalciuria, usually defined by a 24-hour 
urine calcium excretion rate above 4 mg/kg/day, is a 
common feature in stone former patients (8, 23). 
Among hypercalciuric patients, an increased excretion of 
calcium in fasting urine is also frequently found and this 
finding has long been considered an index of a renal 
tubular calcium leak (4, 7, 16, 24-26). However, this 
form of so-called "renal hypercalciuria" has been a mat-
ter of controversy, because most authors were not able 
to find any clear sign of secondary hyperparathyroidism 
in association with fasting hypercalciuria, as one would 
expect in a calcium-wasting nephropathy (5, 9, 16, 19). 
On the other hand, calcium excretion in the fast-
ing urine of normal subjects has been shown to correlate 
with the urinary excretion of hydroxyproline, a reliable 
marker of bone turnover rate (17). 
Indeed, fasting hypercalciuria in stone former pa-
tients has also been found in association with signs of 
increased bone turnover rate (20) and reduced bone min-
eral content (1). Furthermore, a reduced basal secretion 
rate of parathyroid hormone (30) and reduced respon-
siveness of the parathyroid glands to induced hypocal-
cemia (21) was also found in nephrolithiasic patients 
presenting fasting hypercalciuria. 
These findings have suggested the hypothesis that 
fasting hypercalciuria in stone formers could be 
secondary to a primary increase in bone turnover rate. 
However, other studies clearly demonstrated that an 
increased dietary calcium content may cause not only 
greater daily urinary calcium excretion, but also a 
proportional increase in fasting calcium excretion (29), 
especially when high levels of calcitriol are present (18). 
Stone former patients have been reported by many 
authors to have high levels of circulating calcitriol (6, 
12), so that it is in theory possible that fasting hyper-
calciuria in this condition could be of intestinal origin. 
The present study faced the problem of fasting 
hypercalciuria in nephrolithiasic patients in relation to 
dietary calcium intake, bone resorption rate and 
calciotropic hormones. 
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Patients and Methods 
Four hundred and thirty-two patients were sub-
jected to the study in our stone clinic because of a 
history of recurrent passage of renal stones. Of them, 
120 were excluded from the present investigation be-
cause they were affected by primary hyperparathyroid-
ism, or infected calculi or mild renal failure. The 
remaining 312 patients (196 males, aged 18-69 yrs) were 
submitted to the following study protocol. 
Summary of the whole protocol 
- Outpatients basal evaluation: all patients studied 
after a free calcium diet (FCD) or a low calcium diet 
(LCD) (see below). 
- Diet cross-over study: 15 of these patients were 
shifted from LCD to FCD (or vice-versa). 
- Oral calcium load test: 60 of these patients (30 
on LCD and 30 on FCD) were submitted to an oral load 
of calcium. 
Outpatients basal evaluation 
Seventy-four of the above patients were studied 
while on a free calcium home diet (FCD), the other 238 
patients after 15 days of a diet containing: calcium 400 
mg, phosphate 1100 mg, sodium 100 mmol, potassium 
50 mmol, caloric content 40 kcal/kg body weight (LCD). 
Compliance with the diet was assessed by the evaluation 
of urinary content in urea, sulphate and electrolytes (see 
results). 
The protocol consisted in two 24-hour urine col-
lections where the following parameters were evaluated: 
calcium, phosphate, sodium, potassium, chloride, mag-
nesium, citrate, oxalate, uric acid, sulphate, creatinine, 
urea, ammonium. 
In all the patients, after a 12-hour overnight fast, 
a 2-hour urine sample was collected for the measurement 
of: creatinine, calcium, phosphate, hydroxyprol ine, 
c-AMP. 
On the same morning, a blood sample was col-
lected for measurement of: calcium, phosphate, sodium, 
potassium, chloride, magnesium, uric acid, creatine, 
urea, acid-base balance, PTH (intact molecule). In 38 
of these patients (18 on FCD and 20 on LCD, randomly 
chosen among the overall stone former group), calcitriol 
and calcitonin (CT) were measured. 
Diet cross-over inpatient study 
Fifteen patients were randomly allocated to a 
high-normal calcium diet (HCD: containing 1000 mg of 
calcium and comparable to the LCD for the other con-
stituents, see "Outpatients evaluation" paragraph) or to 
LCD (calcium 400 mg) and, after 15 days of stabiliza-
tion, were studied with the same protocol used for out 0 
patients. Thereafter, they were shifted to the other diet 
and after a further 15 days the same study was repeated. 
Calcium load test (OCL) 
Sixty patients (30 on FCD and 30 on LCD) were 
also submitted to an OCL (1 gram of elemental calcium) 
and in urine samples, collected 2 hours before and 4 
240 
hours after the calcium challenge, the following parame-
ters were evaluated: calcium, creatinine, hydroxypro-
line, c-AMP. Furthermore, before and 2 hours after the 
OCL, blood samples were collected for measurement of: 
calcium, acid-base balance, PTH (intact molecule). In 
38 randomly chosen patients (18 on FCD and 20 on 
LCD) CT was also measured before and after the OCL. 
Tubular threshold of phosphate (TTPi) was calcu-
lated by urinary excretion of phosphate and creatinine in 
fasting urine, according to Walton and Bijvoet (31). 
Urinary anion gap was calculated as: (Na + K + 
Ca + Mg mEq) - (Cl mEq + 1.8 x phosphate mmol). 
Electrolytes, creatinine and urea in serum and 
urine were measured by standard methodology (autoana-
1 yzer, absorption spectrophotometry, flame photometry). 
Urinary oxalate and citrate were measured in 
urine collected under HCL by gas-chromatography, 
performed by a capillary column, after extraction and 
derivation with BSTFA; calibration was made with a 4 
points curve. 
Hydroxyproline in urine was estimated by resin 
catalyzed hydrolysis method (11). 
PTH was measured by INCSTAR intact-PTH im-
munoradiometric assay (IRMA), utilizing two different 
policlonal antibodies, purified by affinity chromatogra-
phy, specific for two different regions of the PTH mole-
cule (normal values 7-55 pg/ml). 
Calcitonin was analyzed by IN CST AR radioimmu-
noassay, utilizing an antibody produced in a goat against 
pure synthetic human calcitonin (normal values 20- 70 
pg/ml). 
Calcitriol was determined by a competitive bind-
ing assay, following separation with Sephadex chromato-
graphy (TechnoGenetics) (normal values 15-60 pg/ml). 
Urinary cyclic AMP was determined by radioim-
munoassay, using rabbit antiserum (International CIS-
France). 
Statistics were calculated utilizing t-test for paired 
data, anova, chi-square test, simple and multiple regres-
sion analysis and non parametric tests, when appropri-
ate, using a statistic package (BMDP) implemented on an 
IBM AT computer. 
Results 
Outpatient basal evaluation 
The two groups of patients studied in basal condi-
tion on the 2 different diets were substantially identical 
as regards the major clinical data (Table 1). 
The daily urinary excretion of urea nitrogen, sul-
fate, phosphate, uric acid and ammonium, indirect in-
dices of proteic content and acidic load of the diet, were 
not significantly different in the 2 groups of patients; 
however, urinary anion gap was significantly higher in 
patients on LCD (Table 2). 
Table 3 shows the pattern of daily urine composi-
tion as regards calcium, sodium, oxalate and citrate ex-
cretion and calcium/citrate index in the 2 groups. As 
expected, calcium excretion was higher on FCD; sodium 
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Figure I. Relationship between daily urinary calcium 
excretion and calcitonin serum levels in stone former 
patients. A good linear direct correlation is evident 
(y = 17.6 + 0.15 x; r = 0.502; p < 0.001). 
daily urine output was also higher during FCD, while no 
difference in oxalate excretion was observed between the 
two diets. A very impressive increase in citrate excre-
tion accompanied the LCD, with a consequent significant 
reduction of calcium/citrate index. 
The fasting urine excretion of calcium and hy-
droxyproline, corrected by creatinine excretion, and the 
fasting values of urinary c-AMP, corrected by creatinine 
clearance, and of TTPi are shown in Table 4. The val-
ues of urinary calcium in fasting urine did not differ in 
the 2 groups of patients. On the other hand, hydroxy-
proline excretion was strikingly greater in patients on 
LCD. It is worth noting that urinary c-AMP was re-
duced and TTPi increased during LCD. 
The serum concentrations of calcium, phosphate, 
bicarbonate and calciotropic hormones are reported in 
Table 5. No significant difference resulted in serum cal-
cium concentration, PTH and vit D in the 2 groups. 
Phosphate levels were slightly, but significantly higher 
in patients on LCD. CT concentration was significantly 
higher during FCD. Furthermore, the serum levels of 
CT were directly correlated with the amount of daily 
urinary calcium (Fig. 1). 
Diet cross-over inpatients study 
Table 6 shows the effects of shifting from HCD 
to LCD, or vice-versa, in 15 inpatients, after 15 days of 
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Figure 2 . Relationship between changes in hydroxypro-
line excretion and its basal values (changes OHP/Cr = 
4.34 - 0.43 x basal OHP/Cr; r = 5.13, p < 0.001) 
stabilization with each diet, on daily urinary calcium ex-
cretion, fasting calcium and hydroxyproline urine o_ut-
put. On the LCD, together with an expected_ reduct1~n 
of daily calcium excretion in urine, a ma:ked inc:ease in 
bone resorption index was evident. Fasting calcium ex-
cretion also increased, but this change did not reach a 
statistically significant value. 
OCL test 
The changes in calcium and hydroxyproline fast-
ing urinary excretion and serum calcium concentration 
after an OCL, in 30 patients on FCD and 30 on LCD, 
are shown in Table 7. OCL induced an increase in cal-
cium excretion in both groups, but this effect was signif-
icantly greater in the FCD group. On the other hand, 
the OCL induced a significant reduction in the excretion 
of hydroxyproline only in the LCD group. No substan-
tial differences resulted between the 2 groups as regards 
serum calcium changes. 
The changes in calciotropic hormone after OCL 
are shown in Table 8. Again the basal values of CT and 
c-AMP were higher in the FCD group. However, the 
changes observed after the OCL were wholly compa:a-
ble. PTH was markedly inhibited by OCL, but no sig-
nificant difference was evident between the 2 groups. 
Figure 2 shows how the changes in hydroxypro-
line urinary excretion were negatively correlated with its 
basal values. 
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Table 1. Most relevant clinical data of the stone former patients studied on a free calcium home-diet (FCD) or on 
controlled low calcium diet (LCD; Ca 400 mg). Values are expressed as mean ± se (standard error). 
Number Sex Age Body weight Stone Activity Creat. Clear. 
(M/F) (years) (kg) (no.stone/ 2 last yrs.) (ml/min) 
FCD 74 50/24 42.2±1.7 72.1±2.0 3.2±0.5 105.0±3.6 
LCD 238 146/92 39.6±0.9 70.2± 1.2 2.8± 1.2 105.6± 1.8 
p n.s. n. s. n. s. n. s. n. s. 
Table 2. Daily urinary excretion of dietary proteic content related products in stone former patients on FCD and 
LCD. (mean ± se). 
Urea N. (g) Sulphate (mEq) Phosphate (mg) Ammonium (mEq) Uric Acid (mg) An.Gap. (mmol) 
FCD 10.7±0.4 20.4± 1.0 826±38 33.0±2.9 598±26 22.9± 10.8 
LCD 8.6±1.l 20.8± 1.7 754± 18 30.2±2.5 612± 14 32.0± 1.5 
p n.s. n. s. n.s. n.s. n.s. 0.05 
Table 3. Daily urinary excretion of calcium, sodium, oxalate and citrate and calcium/citrate index values during 
FCD and LCD. (mean ± se). 
Calcium Sodium Oxalate Citrate Ca/Cit 
mg mEq mmol mmol mmol/mmol 
FCD 245 ± 15 171 ±8 0.48±0.03 2.7±0.2 2.70±0.02 
LCD 184± 6 114±4 0.52±0.04 3.7±0.4 1.69±0.02 
p < 0.001 < 0.001 n. s. < 0.01 < 0.01 
normal values < 300 M; < 250 F < 0.50 1.8-4.8 
Table 4. Values of calcium and hydroxyproline excretion (corrected by creatinine), of c-AMP (corrected by GFR), 
and of TTPi in fasting urine collected during FCD and LCD. (mean ± se) 
Ca/Cr (mg/mg) OHP/Cr (mg/g) c-AMP (nmol/dl GFR) TTPi (mg/di) 
FCD 0.124±0.008 I 8.8± 1.0 4.9±4.1 2.85 ±0.09 
LCD 0.118±0.003 25.0±0.9 3.9±5.0 3.24±0.04 
p n. s. < 0.001 < 0.01 < 0.001 
normal values < 0.110 < 25 < 4.5 2.2-4.4 
Table 5. Serum values of calcium, phosphate, bicarbonate and calciotropic hormones during FCD and LCD (the 
values of l,25(OH)i Vit D and CT are referred only to 42 patients, see patients and methods). (mean ± se). 
Ca (mg/di) Pi (mg/di) HCO 3 (mEq/1) PTH-int (pg/ml) I ,25(OH)i (pg/ml) CT (pg/ml) 
FCD 9.71 ±0.06 3.05 ±0.07 24.2±0.3 20.4± 1.6 38.4±2.3 67.3±9.6 
LCD 9.66±0.03 3.27±0.04 23.9±0.4 16.7±3.8 31.0±2.2 33.7±5.2 
p n.s. < 0.01 n.s. n. s. n.s. < 0.01 
normal values 8.9-10.4 2.4-4.5 22-26 < 50 20-75 20-70 
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Table 6. Effects of shifting from HCD to LCD, or vice-versa, in 15 inpatients, on urinary daily and fasting 
calcium excretion and fasting hydroxyproline urinary output. (mean ± se). 
u-Ca/day (mg) u-Ca/Cr (mg/mg) OHP/Cr (mg/g) 
HCD 304±36 0.141±0.015 17.8±1.5 
LCD 192±26 0.180±0.028 29.6±3.4 
p < 0.002 Il.S. < 0.002 
normal values < 0.110 < 25 
Table 7. Effects of OCL on fasting calcium and hydroxyproline urinary excretion and on serum calcium concentration 
in 2 groups of patients studied respectively on FCD and LCD. (mean ± se). (The "p" values for the differences in 
each group between basal and after load values are represented as •• = p < 0.001 and•= p <0.05; the "p" values 
in the last row are related to the differences between the 2 groups). 
Ca/Cr (mg/mg) OHP/Cr (mg/g) s-Ca (mg/dl) 
fast OCL change fast OCL change fast OCL change 
FCD 0.124 0.204** +0.08 18.9 16.9 -2.0 9.62 9_95** +0.43 
±0.008 ±0.015 ±0.01 ±1. I ± 1.2 ± 1.3 ±0.06 ±0.08 ±0.09 
LCD 0.116 0.159** +0.06 24.7 17. 9** -6.6 9.57 10.01** +0.55 
±0.003 ±0.008 ±0.01 ±0.9 ± 1.2 ± 1.2 ±0.03 ±0.07 ±0.07 
p n.s. < 0.01 < 0.02 < 0.01 n. s. < 0.02 n. s. n. s. n.s. 
Table 8. Effects of OCL on PTH and CT serum concentrations and urinary excretion of c-AMP in the FCD and LCD 
patients. (mean ± se) . (The "p" values for the differences in each group between basal and after load values are 
represented as 
.. 
= p < 0.001; the "p" values in the last row are related to the differences between the 2 groups). 
PTH (pg/ml) 
fast OCL change fast 
FCD 22.3 11.4** - I 0. I 67.2 
± 1.4 ±0.5 ±2.1 ± 10.5 
LCD 17.8 6.29** -11. 63 32.0 
±4.1 ±1.l ±9.8 ±5.4 
p n. s. n. s. n.s. < 0.001 
Finally, with the pooled data from all our pa-
tients, we considered the influence of both daily urinary 
calcium excretion and hydroxyproline urinary output on 
fasting urinary calcium, by a multiple step-wise correla-
tion analysis, reported in Figure 3. 
It is evident that both the independent variables 
play a substantially identical role in affecting the values 
of fasting calcium excretion. 
Discussion 
Evaluation of calcium excretion in fasting urine 
plays a critical role in the classification of stone former 
patients. Three main hypotheses have been proposed to 
explain this finding in stone formers: a renal tubular 
calcium leak (4, 7, 10, 24-26); an increased input from 
intestine affecting urinary calcium excretion even after 
a long fasting period (18, 23, 29); and finally an in-
crease in bone resorption, not dependent on parathyroid 
gland hyperactivity ( l , 20, 21, 30). 
CT (pg/ml) c-AMP (nmol/dl GFR) 
OCL change fast OCL change 
70.9 +3.37 5.04 4.40* -0.63 
±8.1 ±4.42 ±0.35 ±0.46 ±9.50 
32.8 +0.96 3.99 3.51 * -0.59 
±6.2 ±5.07 ±0.16 ±0.27 ± 12.50 
< 0.001 n. s. < 0.01 < 0.01 n.s. 
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Figure 3. Multiple step-wise regression analysis of fast-
ing calcium/creatinine on daily urinary calcium excre-
tion, fasting hydroxyproline/creatinine and fasting Na 
excretion (r = 0.655; p < 0.001). 
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The hypothesis of a tubular leak has been proved 
true only in a minority of cases, mainly represented by 
sponge kidney disease (13), while no real direct or in-
direct evidence of a calcium wasting nephropathy has 
been found in the majority of stone former patients with 
fasting hypercalciuria (5, 9, 16, 19, 22). 
On the other hand, both the other two hypotheses 
could be true. However, if this is the case, one would 
expect to find an increase of fasting calcium either in a 
condition of calcium repletion, for the intestinal calcium 
supply, or in condition of calcium deprivation, if,as 
found by other authors (17), increased bone resorption 
ensues. 
It is already known that a moderate restriction in 
dietary calcium content is frequently prescribed or spon-
taneously chosen by patients who experienced a stone 
event, with an increased risk for bone demineralization. 
Indeed, our data show that an LCD is effective in 
reducing daily urinary calcium excretion, when com-
pared with both an FCD and an HCD, without affecting 
fasting calcium excretion. This first set of results 
confirms that a calcium rich diet, independently of its 
proteic content, can result in increased calciuria; in fact, 
no significant difference of protein related product was 
evident in the urine of FCD and LCD patients, even if a 
slightly greater amount of urea, ammonium and phos-
phate was evident in the urine of FCD patients. The 
possibility that the difference in daily urinary excretion 
of calcium could be dependent on different dietary sodi-
um content exists, but is of secondary importance in our 
opinion because the same difference in calcium excretion 
resulted in the inpatient study between the HCD and 
LCD, containing the same amount of sodium. 
The LCD also resulted in a considerable increase 
in citrate excretion, with a consequent marked ameliora-
tion of the calcium/citrate index (27), resulting in a 
reduction of the potential risk of stone formation. 
In fact, as mentioned above, a slightly higher pro-
teic content of FCD might be the cause of increased 
acidic load and reduced citrate excretion. On the other 
hand, the greater urinary anion gap of LCD patients, in 
the absence of significant differences in ammonium ex-
cretion, might be indicative of a different quality in 
dietary proteic content, with a larger amount of organic 
metabolizable anions contained in LCD, and a potential-
ly greater alkaline supply which could explain the 
increased citrate excretion. 
Another important result was that no real change 
was observed in oxalate excretion between the two diets, 
although the mean excretion values remained on the 
high-normal range. This result is at variance with other 
data present in the literature (2) and the only apparent 
explanation for this difference might be that an increased 
absorption of oxalate during LCD could be counteracted 
by reduced dietary content. However, subsequent stud-
ies have given more insight into the role of oxalate stem-
ming from the diet in causing hyperoxaluria, owing to a 
very low real bioavailability of dietary oxalate (3) and a 
major role for endogenous sources of this salt (28). 
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Whatever the cause of this difference, the LCD was real-
ly effective in reducing the main risk factors for stone 
formation in our patients. 
On the other hand, the LCD resulted in a marked 
increase in hydroxyproline excretion in fasting urine, a 
well known index of bone resorption. This finding was 
evident not only in the outpatient study, but also in 
crossover inpatient protocol, with values almost com-
pletely overlapping for the two studies. The increased 
bone resorption was not accompanied by signs of sec-
ondary hyperactivation of the parathyroid glands, as 
serum PTH remained substantially the same. 
On the other hand, a reduced urinary c-AMP level 
and increased TTPi values were evident during LCD, as 
though reduced parathyroid activity was present. No 
difference in calcitriol serum concentration was found 
which could explain the finding of reduced PTH activity. 
We have no convincing explanation for this finding. It 
is possible however that the duration and the degree of 
calcium deprivation (15 days) were not sufficient to 
stimulate the PTH-Vit D system, and that other as yet 
unexplored factors might have induced the observed mi-
nor changes in PTH activity. In fact, the increased bone 
turnover was certainly not dependent on PTH stimula-
tion. On the other hand, a very impressive difference in 
CT serum levels was present between patients on LCD 
and FCD. Moreover the CT values appeared well relat-
ed to daily calcium excretion in urine, confirming the 
possibility that an increased dietary calcium content can 
stimulate, and conversely a calcium reduction in the diet 
can reduce, CT levels. With the present data we cannot 
be sure that this finding is the explanation for the 
reduced PTH activity found, because only a small 
number of our patients were checked for CT. However, 
this finding could be at least a partial answer to the 
question posed by Liberman and De Vriers nearly 20 
years ago ( 15). 
It is also difficult to propose a primary role for 
CT in modulating bone resorption rate in relation to var-
iable dietary calcium content, because the striking reduc-
tion in hydroxyproline excretion that we found after 
OCL, was not accompanied by any change in CT levels. 
From our data, no clear explanation is evident for 
this "primary" increased bone turnover rate: further 
studies, directed to investigating bone receptor sensitivi-
ty to calciotropic hormones and/or local calcium-regulat-
ing factors, might provide new insights into this issue. 
Indeed, OCL resulted in a normalization of hy-
droxyproline excretion in patients studied on LCD. This 
reduction was accompanied by a lesser increase in calci-
um excretion after OCL in these patients. This finding 
could be explained by reduced intestinal calcium absorp-
tion in the LCD, but this explanation does not seem ten-
able because it is well known that calcium transport in 
the intestine is increased by an LCD (14). Furthermore, 
in our previous study we did not find any difference in 
intestinal calcium absorption, measured by kinetics 
methodology, in relation to different calciuric response 
to OCL (20). 
Diet and Fasting Calcium Excretion in Stone Formers 
It is thus possible that the greater reduction in 
bone turnover together with a reduced calciuric response 
to the OCL could represent a greater uptake by "hungry" 
bone secondary to dietary calcium deprivation. That this 
could be the explanation is indirectly demonstrated by 
the relationship between the level of basal values of bone 
turnover rate and the degree of its reduction after the 
OCL. 
In fact, reviewing our data as a whole, calcium 
excretion in fasting urine was not apparently affected by 
change in calcium intake. This may be because, while 
reducing the intestinal component, the increase in bone 
turnover could compensate for it, resulting in an invari-
ate figure. 
Indeed, the multiple regression analysis demon-
strates that the two components, intestinal and osseous, 
play an almost equal role, so in evaluating the fasting 
levels of urinary calcium, both these variables have to be 
considered. 
In conclusion, an LCD is effective in reducing the 
major risk factors for stone formation, reducing daily 
calcium excretion, increasing citrate in urine, without 
major modifications in oxalate urinary output. However 
this beneficial effect is balanced by an increased bone 
turnover rate. It is worth stressing that a LCD, 
especially if maintained over a long period, could be 
dangerous for bone. 
Finally, the evaluation of fasting urinary calcium 
excretion is a low reliable index because affected by var-
iables that change in the opposite direction with the 
changing of dietary calcium intake, so that any pathoge-
netic classification based on this parameter has to be 
considered with extreme caution. 
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Discussion with Reviewers. 
